Tibotec Therapeutics - Division of Ortho Biotech Products, LP — Marysville, California

Tibotec Therapeutics - Division of Ortho Biotech Products, LP is a clinical research site located in Marysville, California, United States 95901.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Tibotec Therapeutics - Division of Ortho Biotech Products, LP has participated in 23 clinical trials with 1 currently active.

Therapeutic areas: Lung Cancer, Fallopian Tube Cancer, Ovarian Cancer.

Sponsors: SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tibotec Therapeutics - Division of Ortho Biotech Products, LP?

Tibotec Therapeutics - Division of Ortho Biotech Products, LP has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tibotec Therapeutics - Division of Ortho Biotech Products, LP conducted?

Tibotec Therapeutics - Division of Ortho Biotech Products, LP has 23 clinical trials on record, with 1 currently active. Their work covers Lung Cancer, Fallopian Tube Cancer, Ovarian Cancer.

Is Tibotec Therapeutics - Division of Ortho Biotech Products, LP accredited by Crixeo Health?

Yes — Tibotec Therapeutics - Division of Ortho Biotech Products, LP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tibotec Therapeutics - Division of Ortho Biotech Products, LP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.